Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America, 1st Edition
Author :
Edited by Linda M. Liau, MD, PhD, MBA
This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Re
...view more
This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include—but are not limited to—Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.
This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include—but are not limited to—Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.
Author Information
Edited by Linda M. Liau, MD, PhD, MBA, Chair, Department of Neurosurgery
Professor, Department of Neurosurgery, UCLA David Geffen School of Medicine
Director, Brain Tumor Program, UCLA David Geffen School of Medicine
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
Edited by Linda M. Liau, MD, PhD, MBA, Chair, Department of Neurosurgery
Professor, Department of Neurosurgery, UCLA David Geffen School of Medicine
Director, Brain Tumor Program, UCLA David Geffen School of Medicine
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
https://www.asia.elsevierhealth.com/glioblastoma-part-ii-molecular-targets-and-clinical-trials-an-issue-of-neurosurgery-clinics-of-north-america-9780323813051.html297482Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North Americahttps://www.asia.elsevierhealth.com/media/catalog/product/9/7/9780323813051_1.jpg125.09138.99USDInStock/Medicine & Surgery/Neurosurgery/Clinics/Medicine/Neurosurgery/Clinics/Clinics/Medicine/Neurosurgery/Japan Titles43351404388725505461650546665255041525990352631601418269243350884886536505455351451205259833This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include—but are not limited to—Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments. This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include—but are not limited to—Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.00add-to-cart97803238130512021ProfessionalEdited by Linda M. Liau, MD, PhD, MBA20211Book178w x 254h (7.00" x 10.00")Elsevier240Apr 19, 2021IN STOCKEdited by <STRONG>Linda M. Liau</STRONG>, MD, PhD, MBA, Chair, Department of Neurosurgery
Professor, Department of Neurosurgery, UCLA David Geffen School of Medicine
Director, Brain Tumor Program, UCLA David Geffen School of Medicine
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa MonicaClinicsClinicsThe Clinics: SurgeryUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
